BioCryst Pharmaceuticals | GJELD

Debt Endring Dato
Alnylam Pharmaceuticals USD 1.02B 967K 2023-12
Chugai Pharma JPY 14.11B 14.11B 2022-12
DBV Technologies USD 0 0 2022-06
Gilead Sciences USD 24.98B 264M 2023-09
Intra Cellular Therapies USD 0 0 2022-06
Ionis Pharmaceuticals USD 1.27B 14.67M 2023-12
Regeneron Pharmaceuticals USD 2.7B 300K 2023-12
Roche Holding CHF 25.39B 35M 2023-06
Ultragenyx Pharmaceutical USD 0 0 2022-06
Vertex Pharmaceuticals USD 390.3M 13.8M 2023-09



BioCryst Pharmaceuticals GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2024.